TABLE 4.
Adverse effect | No. (%) of patients with: |
||
---|---|---|---|
Discontinuation | Regimen changea | Total | |
Total | 21 (27) | 8 (10) | 29 (38) |
Ototoxicity | 11 (14) | 4 (6) | 15 (19) |
Fatigue | 6 (8) | 1 (1) | 7 (9) |
Tinnitus | 3 (4) | 1 (1) | 4 (5) |
Cough | 1 (1) | 1 (1) | 2 (3) |
Hoarseness | 0 | 1 (1) | 1 (1) |
Nephrotoxicity | 0 | 0 | 0 |
Change of amikacin inhalation from 500 mg once daily to 500 mg three times weekly.